Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective
Authors: Przemyslaw Grygier, Katarzyna Pustelny, Jakub Nowak, Przemyslaw Golik, Grzegorz M. Popowicz, Oliver Plettenburg, Grzegorz Dubin, Filipe Menezes, and Anna Czarna
Published in: Journal of Medicinal Chemistry(tom: nd, strony: nd), Wydawca:ACS Publications
Publication type: article
Subject areas: Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics
SJR best quartile: Q1